210 boxes fluarix trivalent, influenza vaccine, trivalent (PF),syringe,0.5ML
Ended Awarded
- Contract number
- W901UZ25FA029
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
North Dakota National Guard
Army National Guard, Department of Defense
- Obligated
- $32,603
Award facts
- Contract value 100% obligated
- $32,602.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Department of the Army Department of Defense
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of the Army awarded a delivery order to GlaxoSmithKline LLC for the procurement of 210 boxes of Fluarix Trivalent influenza vaccine in 0.5ml syringes, with a ceiling value of $32,602.50. This firm fixed-price delivery order, issued on August 21, 2025, will be performed in Research Triangle Park, North Carolina, with an ultimate completion date of September 13, 2025. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries no set-aside designation.
This delivery order represents a continuation of GlaxoSmithKline's substantial role as a critical supplier of vaccines and pharmaceutical products to multiple federal agencies, including the Department of Defense. The company maintains significant indefinite delivery contracts with agencies such as the Centers for Disease Control and Prevention and the Department of Veterans Affairs for influenza and other vaccines, with contract values ranging into hundreds of millions of dollars. The current award supports the Army's ongoing immunization and disease prevention efforts, leveraging GlaxoSmithKline's established pharmaceutical supply chain and expertise in delivering vaccines for military personnel and government healthcare systems.
Quick answers
Who was awarded contract W901UZ25FA029?
W901UZ25FA029 was awarded to Glaxosmithkline, LLC by North Dakota National Guard (Army National Guard) on August 21, 2025.
How much is contract W901UZ25FA029 worth?
The government has obligated $32,603 on W901UZ25FA029.
Which agency awarded contract W901UZ25FA029?
North Dakota National Guard (Army National Guard) awarded W901UZ25FA029, with funding from Department of the Army (Department of Defense).
Is contract W901UZ25FA029 an order under another contract?
Yes. W901UZ25FA029 is a delivery order under 36F79722D0178, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract W901UZ25FA029 competed?
The extent of competition for W901UZ25FA029 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award